Ticker Details
Amneal Pharmaceuticals, Inc.
IPO Date:	January 1, 1900
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.6B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 2.43%
Avg Daily Range (30 D):	$0.20 | 1.46%
Avg Daily Range (90 D):	$0.19 | 1.54%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	2.13M
Avg Daily Volume (90 D):	1.62M

Trade Size
Avg Trade Size (Sh.):	145
Avg Trade Size (Sh.) (30 D):	102
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	1,941
Avg Institutional Trade:	$1.84M
Avg Institutional Trade (30 D):	$6.52M
Avg Institutional Trade (90 D):	$4.06M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.11M
Avg Closing Trade (30 D):	$11.23M
Avg Closing Trade (90 D):	$5.75M
Avg Closing Volume:	229.87K

News

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Jan 27, 2026 @ 11:02 PM TTM Technologies, Dutch Bros, Advanced Energy Indu... Source: Prnewswire

Dec 5, 2025 @ 1:00 PM Amneal Announces Positive Interim Phase 4 ELEVATE-... Source: Amneal Pharmaceuticals

Dec 2, 2025 @ 1:00 PM Amneal to Participate in Upcoming Investor Confere... Source: Anthony Dimeo

Oct 9, 2025 @ 1:31 PM Teva, Viatris On Investor Watch As White House Spa... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$.02	$.01	$.07
Diluted EPS	$.01	$.01	$.07
Revenue	$2.93B	$784.51M	$724.51M
Gross Profit	$1.08B	$273.97M	$286.25M
Net Income / Loss	$57.62M	$18.13M	$35.61M
Operating Income / Loss	$357.86M	$70.34M	$111.37M
Cost of Revenue	$1.86B	$510.54M	$438.26M
Net Cash Flow	$160.06M	$154.74M	$15.28M
PE Ratio	0.00

Splits
Aug 26, 2013	1:25